Literature DB >> 26299461

Risk factors for postoperative depression: A retrospective analysis of 248 subjects operated on for drug-resistant epilepsy.

Valentina Barbieri1, Francesco Cardinale2, Francesca Gozzo2, Veronica Pelliccia2, Lino Nobili2, Giuseppe Casaceli2, Dalila Fuschillo2, Laura Castana2, Massimo Cossu2, Giorgio Lo Russo2, Laura Tassi2, Orsola Gambini1.   

Abstract

The aim of this retrospective case series analysis was to identify the predictors of postoperative depression (PostOp-D) in a sample of 248 subjects with focal drug-resistant focal epilepsy. The presence or absence of PostOp-D during a 12-month follow-up period was the outcome variable. Demographic, neurologic, psychiatric characteristics, and antiepileptic therapy were the explanatory variables. After preliminary bivariate analysis, a multivariate logistic regression model was fitted to identify variables associated with PostOp-D. Sixty-seven patients (27%) experienced PostOp-D. At multivariate analysis, lifetime depression, age at surgery, and levetiracetam (LEV) are positive predictors of PostOp-D; carbamazepine (CBZ) and anxiety disorders are protective factors. LEV increases the risk for PostOp-D by about half; the relative risk (RR) is 1.48. Conversely, CBZ decreases the risk for PostOp-D by about half (RR 0.59). Our results suggest that careful psychiatric evaluation and follow-up should be recommended for subjects at risk. It is advisable to treat patients with depression before surgery. Antiepileptic drugs should be selected carefully when patients present with not modifiable risk factors, such as positive personal history for depression. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Antiepileptic drugs; Epilepsy surgery; Postoperative depression; Risk factors

Mesh:

Year:  2015        PMID: 26299461     DOI: 10.1111/epi.13118

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  1 in total

1.  Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.

Authors:  Vincenzo Belcastro; Laura Rosa Pisani; Silvio Bellocchi; Paolo Casiraghi; Gaetano Gorgone; Marco Mula; Francesco Pisani
Journal:  J Neurol       Date:  2017-03-18       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.